Clenil Compositum aerosol

Clenil Compositum is a pharmaceutical product used for the treatment of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). It is a combination therapy containing beclometasone dipropionate (a corticosteroid) and salbutamol (a bronchodilator). This specific brand is manufactured and marketed by the Chiesi Farmaceutici Group, a global research-focused pharmaceutical company headquartered in Parma, Italy.

The brand was originally developed by Chiesi in Italy, where the company maintain its main production facilities. Chiesi remains an independent, family-owned group, and it continues to be the ultimate owner and manufacturer of the Clenil line of products, which are distributed internationally to provide respiratory relief to patients across Europe and other global markets.